1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global hERG Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Gene KCNH2
1.2.3 Mutant KCNH2
1.3 Market by Application
1.3.1 Global hERG Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Antiarrhythmic
1.3.3 Antipsychotic
1.3.4 Antibiotics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global hERG Screening Market Perspective (2018-2029)
2.2 hERG Screening Growth Trends by Region
2.2.1 Global hERG Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 hERG Screening Historic Market Size by Region (2018-2023)
2.2.3 hERG Screening Forecasted Market Size by Region (2024-2029)
2.3 hERG Screening Market Dynamics
2.3.1 hERG Screening Industry Trends
2.3.2 hERG Screening Market Drivers
2.3.3 hERG Screening Market Challenges
2.3.4 hERG Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top hERG Screening Players by Revenue
3.1.1 Global Top hERG Screening Players by Revenue (2018-2023)
3.1.2 Global hERG Screening Revenue Market Share by Players (2018-2023)
3.2 Global hERG Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by hERG Screening Revenue
3.4 Global hERG Screening Market Concentration Ratio
3.4.1 Global hERG Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by hERG Screening Revenue in 2022
3.5 hERG Screening Key Players Head office and Area Served
3.6 Key Players hERG Screening Product Solution and Service
3.7 Date of Enter into hERG Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 hERG Screening Breakdown Data by Type
4.1 Global hERG Screening Historic Market Size by Type (2018-2023)
4.2 Global hERG Screening Forecasted Market Size by Type (2024-2029)
5 hERG Screening Breakdown Data by Application
5.1 Global hERG Screening Historic Market Size by Application (2018-2023)
5.2 Global hERG Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America hERG Screening Market Size (2018-2029)
6.2 North America hERG Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America hERG Screening Market Size by Country (2018-2023)
6.4 North America hERG Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe hERG Screening Market Size (2018-2029)
7.2 Europe hERG Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe hERG Screening Market Size by Country (2018-2023)
7.4 Europe hERG Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific hERG Screening Market Size (2018-2029)
8.2 Asia-Pacific hERG Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific hERG Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific hERG Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America hERG Screening Market Size (2018-2029)
9.2 Latin America hERG Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America hERG Screening Market Size by Country (2018-2023)
9.4 Latin America hERG Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa hERG Screening Market Size (2018-2029)
10.2 Middle East & Africa hERG Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa hERG Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa hERG Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories hERG Screening Introduction
11.1.4 Charles River Laboratories Revenue in hERG Screening Business (2018-2023)
11.1.5 Charles River Laboratories Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Detail
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific hERG Screening Introduction
11.2.4 Eurofins Scientific Revenue in hERG Screening Business (2018-2023)
11.2.5 Eurofins Scientific Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA hERG Screening Introduction
11.3.4 Merck KGaA Revenue in hERG Screening Business (2018-2023)
11.3.5 Merck KGaA Recent Development
11.4 Cyprotex Limited
11.4.1 Cyprotex Limited Company Detail
11.4.2 Cyprotex Limited Business Overview
11.4.3 Cyprotex Limited hERG Screening Introduction
11.4.4 Cyprotex Limited Revenue in hERG Screening Business (2018-2023)
11.4.5 Cyprotex Limited Recent Development
11.5 BSYS GmbH
11.5.1 BSYS GmbH Company Detail
11.5.2 BSYS GmbH Business Overview
11.5.3 BSYS GmbH hERG Screening Introduction
11.5.4 BSYS GmbH Revenue in hERG Screening Business (2018-2023)
11.5.5 BSYS GmbH Recent Development
11.6 Creative bioarray
11.6.1 Creative bioarray Company Detail
11.6.2 Creative bioarray Business Overview
11.6.3 Creative bioarray hERG Screening Introduction
11.6.4 Creative bioarray Revenue in hERG Screening Business (2018-2023)
11.6.5 Creative bioarray Recent Development
11.7 Metrion biosciences
11.7.1 Metrion biosciences Company Detail
11.7.2 Metrion biosciences Business Overview
11.7.3 Metrion biosciences hERG Screening Introduction
11.7.4 Metrion biosciences Revenue in hERG Screening Business (2018-2023)
11.7.5 Metrion biosciences Recent Development
11.8 Aurora Biomed
11.8.1 Aurora Biomed Company Detail
11.8.2 Aurora Biomed Business Overview
11.8.3 Aurora Biomed hERG Screening Introduction
11.8.4 Aurora Biomed Revenue in hERG Screening Business (2018-2023)
11.8.5 Aurora Biomed Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details